TIGIT+ CD8+ T cells from patients with AML, GC, or multiple myeloma showed reduced cytokine production, high susceptibility to apoptosis, and significantly reduced proliferation and killing ability. The gene discussed is CD8A; the disease is plasma cell myeloma.